In clinical cohorts of ovarian cancers, we observed that tumors with low FEN1/low BRCA2 co-expression were associated with good PFS (p = 0.038) compared to tumors with high FEN1/high BRCA2 co-expression (Figure 5M). The gene discussed is FEN1; the disease is ovarian cancer.